Hexima Ltd Market Cap ($2.17 Million)
Market Cap & Net Worth: Hexima Ltd (HXL)
Hexima Ltd market cap. Hexima Ltd (AU:HXL) has a market capitalization of $2.17 Million (AU$3.07 Million) as of November 8, 2026. Listed on the AU stock exchange, this Australia-based company holds position #29922 globally and #1719 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hexima Ltd's stock price AU$0.05 by its total outstanding shares 167039629 (167.04 Million). Also see Hexima Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Hexima Ltd Market Cap History (2020–2026)
Hexima Ltd market cap history from 2020 to 2026. Data shows change from $21.87 Million to $6.15 Million (-20.02% CAGR). Check Hexima Ltd (HXL) share price today for real-time trading data and today's change.
Hexima Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hexima Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Hexima Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
34.50x
Hexima Ltd's market cap is 34.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $21.87 Million | $4.08 Million | -$6.87 Million | 5.36x | N/A |
| 2021 | $49.05 Million | $5.81 Million | -$10.02 Million | 8.44x | N/A |
| 2022 | $2.36 Million | $1.48 Million | -$1.92 Million | 1.59x | N/A |
| 2023 | $2.13 Million | $61.67K | -$933.87K | 34.50x | N/A |
Competitor Companies of HXL by Market Capitalization
Companies near Hexima Ltd in the global market cap rankings as of November 8, 2026. Also see Hexima Ltd (HXL) total assets for a full breakdown of the balance sheet.
Key companies related to Hexima Ltd by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6116 globally with a market cap of $1.90 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #10613 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11077 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11473 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6116 | Twenty One Capital, Inc. | NYSE:XXI | $1.90 Billion | $5.48 |
| #10613 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.21 |
| #11077 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11473 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
Market Capitalization of Hexima Ltd (2020–2026)
Market capitalization of Hexima Ltd from 2020 to today. Between 2020 and today, Hexima Ltd's market cap moved from $21.87 Million to $ 6.15 Million, with a yearly change of -20.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$6.15 Million | +300.00% |
| 2025 | AU$1.54 Million | 0.00% |
| 2024 | AU$1.54 Million | -27.78% |
| 2023 | AU$2.13 Million | -10.00% |
| 2022 | AU$2.36 Million | -95.18% |
| 2021 | AU$49.05 Million | +124.32% |
| 2020 | AU$21.87 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 7th, 2026 the market cap of Hexima Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.17 Million USD |
| MoneyControl | $2.17 Million USD |
| MarketWatch | $2.17 Million USD |
| marketcap.company | $2.17 Million USD |
| Reuters | $2.17 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hexima Ltd
Hexima Limited does not have significant operations. It focuses on exploration of transactions with third parties, which could enable the value of the company's assets. Previously, the company was involved in the research and development of plant-derived proteins for applications as human therapeutics. Hexima Limited was incorporated in 1997 and is headquartered in Carlton, Australia.